Improve multiple myeloma diagnosis investigations by implementing testing panels - St. Elizabeth Healthcare

25 Sept 2025

In this case study, Binding Site presents the advantages of integrating testing panels into the diagnostic investigation process for multiple myeloma, drawn from the experiences of St. Elizabeth Healthcare, Edgewood, KY, US.

By implementing a testing panel for myeloma that combines serum free light tests (sFLC) and serum protein electrophoresis (SPE) tests into a single order, St. Elizabeth Healthcare observed significant benefits.

Optilite® Freelite® Assays

Binding Site

Detect and monitor Multiple Myeloma (MM) with Freelite® assays. The time-tested and proven solution for kappa and lambda serum free light chain (sFLC) analysis

(0)

Links

Tags